Log In
Print
BCIQ
Print
Print this Print this
 

diclofenac (Pennsaid 2%) (MNK-395)

Also known as: Pennsaid Viscous Solution (formerly Pennsaid Gel)

  Manage Alerts
Collapse Summary General Information
Company Nuvo Research Inc.
DescriptionTopical NSAID 2% gel formulation
Molecular Target
Mechanism of ActionNSAID
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPain
Indication DetailsTreat osteoarthrits knee pain
Regulatory Designation

U.S. - Undisclosed Review (Treat osteoarthrits knee pain)

Partner

Endo International plc; Horizon Pharma plc; NovaMedica LLC


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$45.0M

$45.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today